UNITED STATES
|
||||
SECURITIES AND EXCHANGE COMMISSION
|
||||
Washington, D.C. 20549
|
||||
FORM 10-Q/A
|
||||
Amendment No. 1
|
||||
(Mark One)
|
||||
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||
For the quarterly period ended September 30, 2010
|
||||
OR
|
||||
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||
For the transition period from ________________ to ______________
|
||||
Commission File Number: 001-14273
|
||||
CORE LABORATORIES N.V.
|
||||
(Exact name of registrant as specified in its charter)
|
||||
The Netherlands
|
Not Applicable
|
|||
(State of other jurisdiction of
|
(I.R.S. Employer Identification No.)
|
|||
incorporation or organization)
|
||||
Herengracht 424
|
||||
1017 BZ Amsterdam
|
||||
The Netherlands
|
Not Applicable
|
|||
(Address of principal executive offices)
|
(Zip Code)
|
|||
(31-20) 420-3191
|
||||
(Registrant's telephone number, including area code)
|
||||
None
|
||||
(Former name, former address and former fiscal year, if changed since last report)
|
Large accelerated filer ý
|
Accelerated filer ¨
|
Non-accelerated filer ¨
|
Smaller reporting company ¨
|
(Do not check if a smaller reporting company)
|
Exhibit No.
|
Exhibit Title
|
Incorporated by reference from the following documents
|
||
31.1
|
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
Previously filed with our Quarterly Report on Form 10-Q filed October 25, 2010
|
||
31.2
|
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
Previously filed with our Quarterly Report on Form 10-Q filed October 25, 2010
|
||
32.1
|
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Previously furnished with our Quarterly Report on Form 10-Q filed October 25, 2010
|
||
32.2
|
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
Previously furnished with our Quarterly Report on Form 10-Q filed October 25, 2010
|
||
101.INS
|
XBRL Instance Document
|
Furnished herewith
|
||
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Furnished herewith
|
||
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Furnished herewith
|
||
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Furnished herewith
|
||
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Furnished herewith
|
CORE LABORATORIES N.V.
|
|||
By:
|
Core Laboratories International B.V., its
|
||
Managing Director
|
|||
Date:
|
October 26, 2010
|
By:
|
/s/ Richard L. Bergmark
|
Richard L. Bergmark
|
|||
Chief Financial Officer
|
|||
(Duly Authorized Officer and
|
|||
Principal Financial Officer)
|
EXHIBIT NO.
|
ITEM
|
|
31.1
|
Certification of CEO Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)
|
|
31.2
|
Certification of CFO Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)
|
|
32.1
|
Certification of the CEO Pursuant to 18 U.S. C. Section 150, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
|
|
32.2
|
Certification of the CFO Pursuant to 18 U.S. C. Section 150, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
|
|
101.INS
|
XBRL Instance Document (2)
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document (2)
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document (2)
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document (2)
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document (2)
|